PROCEPT BioRobotics Corp (PRCT) stock
PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/3051% below fair value
$23.51+0.17 (+0.73%)
Close on Nov 12, 2026Market cap $1.35BP/E –Yield –
PROCEPT BioRobotics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
PROCEPT BioRobotics's total debt was $51.77M at Sep 30, 2026. For fiscal 2025 it was $51.62M, up 0.3% from the year before. The highest annual figure on record is $51.62M in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $51.62M | +0.3% |
| FY2024 | Dec 31, 2024 | $51.47M | +0.3% |
| FY2023 | Dec 31, 2023 | $51.34M | +0.2% |
| FY2022 | Dec 31, 2022 | $51.21M | +2.4% |
| FY2021 | Dec 31, 2021 | $50.00M | +2.1% |
| FY2020 | Dec 31, 2020 | $48.96M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $51.77M | +0.4% |
| Q2 FY2026 | Jun 30, 2026 | $51.72M | +0.4% |
| Q1 FY2026 | Mar 31, 2026 | $51.66M | +0.3% |
| Q4 FY2025 | Dec 31, 2025 | $51.62M | +0.3% |
| Q3 FY2025 | Sep 30, 2025 | $51.57M | +0.2% |
| Q2 FY2025 | Jun 30, 2025 | $51.52M | +0.2% |
| Q1 FY2025 | Mar 31, 2025 | $51.50M | +0.2% |
| Q4 FY2024 | Dec 31, 2024 | $51.47M | +0.3% |
| Q3 FY2024 | Sep 30, 2024 | $51.44M | +0.3% |
| Q2 FY2024 | Jun 30, 2024 | $51.40M | +0.3% |
| Q1 FY2024 | Mar 31, 2024 | $51.37M | +0.3% |
| Q4 FY2023 | Dec 31, 2023 | $51.34M | +0.2% |
| Q3 FY2023 | Sep 30, 2023 | $51.31M | +1.2% |
| Q2 FY2023 | Jun 30, 2023 | $51.28M | +1.5% |
| Q1 FY2023 | Mar 31, 2023 | $51.24M | +2.0% |
| Q4 FY2022 | Dec 31, 2022 | $51.21M | +2.4% |
| Q3 FY2022 | Sep 30, 2022 | $50.69M | +1.9% |
| Q2 FY2022 | Jun 30, 2022 | $50.51M | +3.2% |
| Q1 FY2022 | Mar 31, 2022 | $50.25M | – |
| Q4 FY2021 | Dec 31, 2021 | $50.00M | – |
| Q3 FY2021 | Sep 30, 2021 | $49.76M | – |
| Q4 FY2020 | Dec 31, 2020 | $48.96M | – |
See a number that looks wrong?